DEH SEC filings, in plain English
Everything D8 Holdings Corp. has filed with the SEC that we hold — 40 filings, newest first, 5 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: 8-K of Vicarious Surgical, Inc. Items 1.01 and 2.01: on July 21, 2026 stockholders approved the transfer of all or substantially all of the Company's assets through an assignment for the benefit of creditors, subject to the Board so determining; the Board so determined the same day and the Company entered a general assignment for the benefit of creditors with Vicarious Liquidation, LLC as assignee, filed as Exhibit 10.1. Item 5.02: all seven directors gave notice of resignation from the Board and its committees, effective on the filing of a Form 15 with the SEC. Why it matters: This is the wind-down. The Company also terminated CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa and CMO Dr. Barry Greene effective at the close of business on July 21, 2026, with From, Sachs and Khalifa entitled to contractual severance; the report states $672,699 for Mr. From and $779,190 for Mr. Sachs, each with full vesting of time-based equity awards. A Form 15 filing would end Exchange Act reporting.
What changed: Item 5.02: on June 24, 2026 Sarah Romano notified the board of Vicarious Surgical Inc. of her resignation as Chief Financial Officer, effective July 22, 2026 or such later date as may be mutually agreed. The filing states her resignation was not the result of any disagreement with the company on any matter relating to its operations, policies or practices, and that she will continue to serve as Chief Financial Officer through the effective date. No successor or interim arrangement is named. Why it matters: A CFO departure at a pre-revenue medical device company matters more than at a mature issuer, because financing and cash-runway management sit with that role. The express statement that there was no disagreement removes the accounting-dispute reading. What the filing does not provide is a successor or an interim plan, so the open question for a holder is who signs the next set of financial statements and on what timetable.
What changed: Vicarious Surgical Inc. (successor to SPAC D8 Holdings) called a special meeting for Monday, July 21, 2026 at 9:00 a.m. ET, in person at 78 Fourth Avenue, Waltham, Massachusetts, record date June 10, 2026, to approve an assignment for the benefit of creditors followed by voluntary dissolution and liquidation under a plan attached as Annex A. Based on cash, money market funds, U.S. treasury and agency securities as of March 31, 2026, the company does not expect to continue as a going concern for any significant period. 6,477,365 Class A and 653,990 Class B shares are outstanding. Why it matters: An assignment for the benefit of creditors places company assets under an assignee who pays creditors first, so common stockholders receive residual value only if creditors are made whole, and the company's own going-concern language says cash is insufficient to continue for any significant period. Management adds that strategic alternatives and financing are unlikely to succeed. For anyone holding the former SPAC's shares this is effectively a zero: the trust redemption right was extinguished at the business combination and there is no floor beneath the equity now.
What changed: Vicarious Surgical Inc. filed a preliminary proxy for a Special Meeting of Stockholders on Monday, July 20, 2026 at 9:00 a.m. Eastern, in person at 78 Fourth Avenue, Waltham, Massachusetts. One proposal is on the ballot: approval of an assignment for the benefit of creditors followed by a voluntary dissolution and liquidation under the plan of dissolution at Annex A, including authority for the board to abandon the assignment and dissolution. The record date is June 10, 2026, on which 7,131,355 shares of Class A and Class B common stock were outstanding and entitled to vote. Why it matters: Approval requires the affirmative vote of a majority in voting power of the outstanding common stock, not merely of votes cast, so shares not voted count against it. If approved, the company says the assignment would be effected shortly after the meeting and the certificate of dissolution filed shortly after that, with no further stockholder approval required. All property passes to a third-party assignee who liquidates it and pays creditors first; stockholders receive only what remains, and the company states it cannot predict the amount or timing of any distribution.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“date of issuance of these financial statements, and accordingly, this raises substantial doubt about the Company’s ability to continue as a going concern. Due to a reduction in headcount effective March 6, 2026, the Company expects”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Vicarious Surgical Inc., the successor to D8 Holdings Corp, called a special meeting for 9:00 a.m. Eastern Time on Wednesday, April 8, 2026, held in person at 78 Fourth Avenue, Waltham, Massachusetts, record date March 16, 2026, to approve a charter amendment effecting a reverse stock split of both Class A and Class B common stock. Why it matters: Trading was already suspended on March 3, 2026 for a market capitalization below $15 million, so this reverse split is an attempt to restore a listing that has effectively been lost rather than to prevent a deficiency. Holders face an illiquid security in the meantime. The same company would go on to propose an assignment for the benefit of creditors and dissolution weeks later, so the split addressed a symptom while the underlying solvency problem was unresolved.
- What changed vs 2025-03-17mandate language changed
mandate language, going-concern doubt1 moved · 1 with no prior record of ours
- Mandate language
- We intend to pursue additional intellectual property protect…we intend to focus on increasing system utilization by suppo…
- Going-concern doubt
- stated · unchanged
The clause “0-K. Risks Related to Our Financial Condition and Capital Requirements There is substantial doubt about whether we can continue as a going concern. To date, we have earned no revenues and have incurred an accumulated deficit of $246.1”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.